Squarepoint Ops LLC Sellas Life Sciences Group, Inc. Transaction History

Squarepoint Ops LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$5.5 - $11.71 $55,445 - $118,048	-10,081 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.45 - $17.66 $24,698 - $178,030	10,081 New	10,081 $59,000
Q3 2020 Nov 16, 2020	SELL	$1.88 - $3.58 $60,923 - $116,013	-32,406 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.53 - $3.93 $49,581 - $127,355	32,406 New	32,406 $95,000

5.69M

1.67M

74.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $20.3M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.